Macular degeneration trials in Romania

2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  Where

  Bucharest, Cluj-Napoca

  Age

  50 years and over

  People

  272 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07441642 · EU 2025-523704-77-00
• Phase 1Taking people
  Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

  Where

  Bucharest, Cluj-Napoca

  Age

  50 years and over

  People

  54 worldwide

  Run by

  Regeneron Pharmaceuticals

  See details and how to joinNCT07230834 · EU 2025-521758-40-00